DLC is pleased that the Centers for Medicare and Medicaid Services (CMS) has issued guidance clarifying that Medicare Part D Plan Sponsors may provide coverage for products such as the Omnipod System under the Medicare Part D (prescription drug) program. DLC, in conjunction with other diabetes organizations, advocated strongly for this guidance.Click below to view a PDF of the press release from Insulet Corporation, manufacturer of the Omnipod.Medicare Part D (Prescription Drug) Plans May Now Cover Omnipod®Insulet Corporation has also made available a Medicare FAQ document that can be found here:Medicare FAQ
